
Site burden is now measured through satisfaction surveys, in-the-moment check-ins, and adoption patterns, but each method catches a different moment, and the gaps between them decide whether teams can act before burden becomes risk.
Grand View Research, Inc. released a new report with findings that predict the global clinical trial supplies market will reach $3.3 billion by 2025-a growth rate of 7.3%. Driving factors include the rising volume of clinical trial studies in tandem with the growing complexity in conduction of these trials.
Read the full release






